SOUTH SAN FRANCISCO, Calif. & LONDON--(BUSINESS WIRE)--insitro, a machine learning-driven drug discovery and development company, and Genomics England today announced a collaboration to bring ...
Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced the successful completion and delivery ...
Today, an international group of leading scientists publish recommendations for updating existing standards for determining the disease-causing potential of genomic variants, harnessing insights from ...
SAN JOSE, Calif., Sept. 10, 2020 /PRNewswire/ -- Quantum Corp. (NASDAQ: QMCO) today announced that Genomics England has expanded their Quantum ActiveScale object storage solution as part of an ...
Revvity (RVTY) announced an expansion of its work with Genomics England that leverages both organizations’ expertise and resources to advance critical genomic initiatives across the United Kingdom.
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now ...
Genomics England has deployed an enterprise imaging system from supplier Sectra to link radiology and pathology images with whole genome sequencing data. The implementation of the system is part of ...
LONDON, 19 July 2022 – Today, an international group of leading scientists publish recommendations for updating existing standards for determining the disease-causing potential of genomic variants, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results